Opinion: On “Funding Research in Africa”

A letter to The Scientist from NIH Director Francis Collins and Wellcome Trust Director Jeremy Farrar

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, NICOLAS RAYMONDWe are writing to comment on your November 12 article entitled “Funding Research in Africa” by Paula Park. The article appropriately identified a very real problem—the dearth of basic research funding for scientists in many African countries. While the US National Institutes of Health (NIH), the Wellcome Trust, and others fund a considerable amount of research in Africa, many of those awards are made to non-African institutions and scientists, who in turn sub-contract for collaborations with their African colleagues. However, Park apparently did not appreciate that the proportion of awards made directly to African scientists and institutions is steadily increasing, and now accounts for about 40 percent of Wellcome Trust and 63 percent of NIH funding for research in Africa.

As a prominent example of this increasing focus on direct funding to African investigators, the NIH and the Wellcome Trust recently established a collaborative program, called Human Health and Heredity in Africa (H3Africa). H3Africa directly funds African scientists at African institutions to conduct research on the genomic and environmental bases of health problems of importance in Africa. Support is being provided for basic research, improved infrastructure, and training. One of the long-term goals of H3Africa is to increase the ability of African scientists to compete for international research funding.

NIH and the Wellcome Trust have, together, committed the equivalent of at least $76 million to H3Africa for the period 2012–2016, and both agencies will consider extending the program for an additional five years pending the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Francis S. Collins

    This person does not yet have a bio.
  • Jeremy Farrar

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio